Angiodysplasia future or investigational therapies: Difference between revisions
Jump to navigation
Jump to search
Nikita Singh (talk | contribs) No edit summary |
Nikita Singh (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
In a study, significantly lower levels of Ang-1 and TNF-α were found in patients with small bowel angiodysplasia as compared to the controls. | In a study, significantly lower levels of Ang-1 and TNF-α were found in patients with small bowel angiodysplasia as compared to the controls. Despite similar progress in some other studies, the use of chemical markers of angiogenesis as diagnostic tool for angiodysplasia is still at an early stage and would require further research into this area. | ||
Further details of the pathogenesis of angiodysplasia is required for better diagnostic and therapeutic options of this condition. | |||
<br /> | <br /> | ||
<references /> | |||
Revision as of 07:48, 15 October 2021
In a study, significantly lower levels of Ang-1 and TNF-α were found in patients with small bowel angiodysplasia as compared to the controls. Despite similar progress in some other studies, the use of chemical markers of angiogenesis as diagnostic tool for angiodysplasia is still at an early stage and would require further research into this area.
Further details of the pathogenesis of angiodysplasia is required for better diagnostic and therapeutic options of this condition.